Back to Sectors

CBRRF

Chain Bridge I
2 filings tracked
financialsasset managementMICRO (<$300M)

Signal Magnitude Chart

NEUTRAL | 30% | 5/15/2026 | management changeBEARISH | 70% | 5/15/2026 | dilution riskBEARISH | 90% | 5/15/2026 | regulatory actionBEARISH | 60% | 5/15/2026 | margin compressionNEUTRAL | 30% | 5/15/2026 | management changeBEARISH | 70% | 5/15/2026 | dilution riskBEARISH | 90% | 5/15/2026 | regulatory actionBEARISH | 60% | 5/15/2026 | margin compressionMay 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

neutralMay 15

Company is operating under a new mandate following the termination of the Phytanix merger.

management change
30%
bearishMay 15

Heavy reliance on convertible notes and warrants that will dilute shareholders upon any future merger.

dilution risk
70%
bearishMay 15

Delisting from Nasdaq and subsequent move to OTCID Basic Market due to float requirements.

regulatory action
90%
bearishMay 15

Quarterly net loss of $436,659 driven by G&A expenses and derivative fair value changes.

margin compression
60%
neutralMay 15

Company is operating under a new mandate following the termination of the Phytanix merger.

management change
30%
bearishMay 15

Heavy reliance on convertible notes and warrants that will dilute shareholders upon any future merger.

dilution risk
70%
bearishMay 15

Delisting from Nasdaq and subsequent move to OTCID Basic Market due to float requirements.

regulatory action
90%
bearishMay 15

Quarterly net loss of $436,659 driven by G&A expenses and derivative fair value changes.

margin compression
60%

Filing History

10-QMay 15, 2026

Chain Bridge I stands at a critical crossroads, balancing a streamlined structural framework against a deteriorating financial position. While the removal of asset hurdles and the extension of the termination date to November 2026 provide a theoretical path to success, the company is fighting a war of attrition against a dwindling cash balance and a mountain of debt. The transition to the OTCID market further complicates the ability to attract a high-quality target or maintain a stable shareholder base. Ultimately, the investment thesis has shifted from a standard SPAC play to a binary bet on management's ability to secure a merger. The presence of the Trust Account provides some downside protection, but the overarching risk is a cash-starved wind-up. Investors are now weighing the sponsor's continued financial commitment against the systemic risks of delisting and the looming 2026 liquidation deadline.